Australian Biotechnology News

Stories about: GENETIC TECHNOLOGIES

  • +

    GTG responds to BRCA row 24/07/2008 13:36:01

    Genetic Technologies responds to criticism over patent enforcement decision
  • +

    Freeze my puppies 23/07/2008 15:40:20

    Genetic Technologies acquires Frozen Puppies Dot Com
  • +

    Genetic Technologies gets tough 14/07/2008 12:55:36

    GTG to enforce rights to BRCA patents
  • +

    End of an era for GTG 20/09/2007 11:23:44

    New head for Melbourne's Genetic Technologies as founder steps back.
  • +

    GTG forms alliance with US MetaMorphix 27/02/2006 13:30:18

    Melbourne's Genetic Technologies (ASX:GTX, Nasdaq:GENE) has formed a strategic alliance with MetaMorphix, a developer of new genetic markers.
  • +

    In brief: GTG, Life Therapeutics, AusBiotech, CyGenics 21/02/2006 13:25:47

    Genetic Technologies (ASX:GTG; Nasdaq:GENE) has appointed London-based lawyer SJ Berwin to help the company expand its licensing program for its non-coding patents in the UK and in Europe
  • +

    GTG primed to expand non-coding DNA licensing 30/01/2006 09:29:30

    Mervyn Jacobson, executive chairman of biotech firm Genetic Technologies (ASX:GTG, Nasdaq:GENE), says his company is poised to launch an extensive international search for license partners for its far-reaching non-coding DNA patents.
  • +

    CEO sees GTG leading the way for Aust biotech 13/12/2005 09:39:35

    A major court victory against US firm Applera will put Genetic Technologies (ASX:GTG) in a leadership position in Australian biotechnology, the firm's CEO has predicted.
  • +

    GTG celebrates win over Applera in patent battle 12/12/2005 14:29:12

    An elated Dr Mervyn Jacobson, CEO of Genetic Technologies (ASX:GTG, NASDAQ:GENE), flew back to Melbourne from San Francisco this morning after slaying his company's most reluctant dragon, giant US rival Applera.
  • +

    More delays in GTG-Applera case 05/12/2005 14:54:33

    Two deadlines have come and gone, and a third expires today for Melbourne gene-testing company Genetic Technologies (ASX:GTG; NASDAQ:GENE) and US firm Applera, who were due to announce a resolution of their licensing dispute in California today.
  • +

    Start-up Haplomics to muscle in on gene-testing market 01/12/2005 15:03:25

    Melbourne gene-testing company Genetic Technologies (ASX:GTG), currently engaged in a protracted court case with giant US rival Applera over licensing and royalties for GTG's controversial non-coding DNA patents, has a potential rival in its own backyard.
Additional Resources
Newsletter Subscription
Sign up for our Australian Life Scientist newsletters!
 
Jobs